JP2022544836A5 - - Google Patents
Info
- Publication number
- JP2022544836A5 JP2022544836A5 JP2022511023A JP2022511023A JP2022544836A5 JP 2022544836 A5 JP2022544836 A5 JP 2022544836A5 JP 2022511023 A JP2022511023 A JP 2022511023A JP 2022511023 A JP2022511023 A JP 2022511023A JP 2022544836 A5 JP2022544836 A5 JP 2022544836A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- composition according
- mannose
- therapeutic agent
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962888727P | 2019-08-19 | 2019-08-19 | |
| US62/888,727 | 2019-08-19 | ||
| PCT/US2020/047036 WO2021034953A1 (en) | 2019-08-19 | 2020-08-19 | Compositions and related methods for the ablation of m2 macrophages and myeloid derived suppressor cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022544836A JP2022544836A (ja) | 2022-10-21 |
| JP2022544836A5 true JP2022544836A5 (https=) | 2023-08-22 |
Family
ID=74647058
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022511023A Pending JP2022544836A (ja) | 2019-08-19 | 2020-08-19 | Ｍ２マクロファージおよび骨髄系由来サプレッサー細胞を除去するための組成物ならびに関連する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20210052639A1 (https=) |
| EP (1) | EP4017546A4 (https=) |
| JP (1) | JP2022544836A (https=) |
| CN (1) | CN114555131A (https=) |
| CA (1) | CA3151519A1 (https=) |
| IL (1) | IL290593A (https=) |
| WO (1) | WO2021034953A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021019187A2 (pt) * | 2019-03-27 | 2021-12-21 | Navidea Biopharmaceuticals Inc | Método para repolarização de um macrófago associado a tumor de m2 a m1, e, composto para repolarização de um macrófago associado a tumor de m2 a m1 |
| CA3192041A1 (en) * | 2020-08-21 | 2022-02-24 | Resolute Science, Inc. | Compositions and methods for targeting tumor-associated macrophages |
| WO2025096664A1 (en) * | 2023-10-31 | 2025-05-08 | The Board Of Trustees Of The Leland Stanford Junior University | Bifunctional cd206-binding molecules and methods of use |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1178838B1 (en) * | 1999-05-14 | 2004-09-29 | The Regents of the University of California | Macromolecular carrier based on dextran for drug and diagnostic agent delivery |
| AU2006204045B2 (en) * | 2005-01-05 | 2010-10-14 | Board Of Regents, The University Of Texas System | Conjugates for dual imaging and radiochemotherapy: composition, manufacturing, and applications |
| JP5320569B2 (ja) * | 2008-06-28 | 2013-10-23 | 公益財団法人神奈川科学技術アカデミー | 高分子ミセル及びそれを有効成分として含有する固形がんの診断又は治療剤 |
| CN114377143A (zh) * | 2013-07-22 | 2022-04-22 | 康德乐健康414有限责任公司 | 用于诊断和治疗与表达cd206的细胞相关的病症的组合物、方法和药盒 |
| CA2955438C (en) * | 2014-07-17 | 2024-07-02 | Ohio State Innovation Foundation | DEXTRANE CONJUGATES TO TARGET MACROPHAGES AND OTHER CELLS EXPRESSING THE D-MANBOSE BINDING TYPE C LECTIN RECEPTOR |
| WO2016118188A1 (en) * | 2015-01-21 | 2016-07-28 | Navidea Biopharmaceuticals, Inc. | Compositions for targeting macrophages and other mannose-binding c-type lectin receptor high expressing cells |
| EP3522899A4 (en) * | 2016-10-07 | 2020-05-06 | Navidea Biopharmaceuticals, Inc. | Compounds and compositions for treating leishmaniasis and methods of diagnosis and treating using same |
| WO2019018815A1 (en) * | 2017-07-21 | 2019-01-24 | Navidea Biopharmaceuticals, Inc. | USE OF 99MTC-TILMANOCEPT AND ASSOCIATED MOLECULAR CONSTRUCTS FOR THE IDENTIFICATION AND DIAGNOSIS OF MALIGNANT TUMORS, AND FOR THE MONITORING OF ANTI-TUMOR THERAPEUTIC INTERVENTIONS |
| BR112021019187A2 (pt) * | 2019-03-27 | 2021-12-21 | Navidea Biopharmaceuticals Inc | Método para repolarização de um macrófago associado a tumor de m2 a m1, e, composto para repolarização de um macrófago associado a tumor de m2 a m1 |
-
2020
- 2020-08-19 US US16/997,648 patent/US20210052639A1/en not_active Abandoned
- 2020-08-19 WO PCT/US2020/047036 patent/WO2021034953A1/en not_active Ceased
- 2020-08-19 CN CN202080070370.6A patent/CN114555131A/zh active Pending
- 2020-08-19 CA CA3151519A patent/CA3151519A1/en active Pending
- 2020-08-19 EP EP20855075.6A patent/EP4017546A4/en not_active Withdrawn
- 2020-08-19 JP JP2022511023A patent/JP2022544836A/ja active Pending
-
2022
- 2022-02-13 IL IL290593A patent/IL290593A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022544836A5 (https=) | ||
| Barry et al. | Exploration of the medical periodic table: towards new targets | |
| Hannon | Metal-based anticancer drugs: From a past anchored in platinum chemistry to a post-genomic future of diverse chemistry and biology | |
| Mjos et al. | Metallodrugs in medicinal inorganic chemistry | |
| Pettenuzzo et al. | Metal-based glycoconjugates and their potential in targeted anticancer chemotherapy | |
| JP2008502584A5 (https=) | ||
| JP2012528890A5 (https=) | ||
| JP2024147816A (ja) | がん治療における免疫モジュレーションのための組合せ | |
| Jadon et al. | An integrative review of Cisplatin: the first metal anti-tumor drug. | |
| US11331297B2 (en) | Polyoxometalate complexes and uses in managing cancer | |
| Allardyce et al. | Medicinal properties of organometallic compounds | |
| JP2025516821A (ja) | 安定性の高い重金属除去組成物およびその用途、剤形、製造方法 | |
| Shah et al. | Intersection of inorganic chemistry and nanotechnology for the creation of new cancer therapies | |
| Kostova | Therapeutic and diagnostic agents based on bioactive endogenous and exogenous coordination compounds | |
| CN102802420A (zh) | 治疗肝癌的方法 | |
| Lee et al. | Impact of standardized Rhus verniciflua stokes extract as complementary therapy on metastatic colorectal cancer: a Korean single-center experience | |
| Jia et al. | Anti-cancer and radio-sensitizing properties of new bimetallic (N-heterocyclic carbene)-amine-Pt (II) complexes | |
| Wani et al. | Gold and its complexes in anticancer chemotherapy | |
| De Wit et al. | Randomised phase II trial of carboplatin and iproplatin in advanced urothelial cancer | |
| JP2022502450A5 (https=) | ||
| CN118946371A (zh) | 靶向psma的放射性药物和检查点抑制剂的组合疗法 | |
| Wani et al. | Therapeutic Potential of Gold Complexes | |
| CN101386629A (zh) | 以3-乙酰氧基-1,1-环丁烷二羧酸根为离去基团的新型水溶性Pt(II)抗癌配合物 | |
| Mei | Review of the toxicological mechanism of anticancer drug cisplatin | |
| EP0686038A1 (en) | Combination cisplatin/tamoxifen therapy for human cancers |